BOURGEON CAPITAL MANAGEMENT LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOURGEON CAPITAL MANAGEMENT LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$39,318
+11.3%
386
+10.3%
0.01%
+12.5%
Q2 2023$35,319
+9.7%
3500.0%0.01%0.0%
Q1 2023$32,200
+1.4%
3500.0%0.01%0.0%
Q4 2022$31,752
+17.6%
3500.0%0.01%
+14.3%
Q3 2022$27,000
-10.0%
3500.0%0.01%
-12.5%
Q2 2022$30,000
-3.2%
3500.0%0.01%
+14.3%
Q1 2022$31,0000.0%3500.0%0.01%
+16.7%
Q4 2021$31,000
-52.3%
350
-56.2%
0.01%
-57.1%
Q3 2021$65,000
-11.0%
8000.0%0.01%
-12.5%
Q2 2021$73,000
+7.4%
8000.0%0.02%
+6.7%
Q1 2021$68,000
-98.8%
800
-98.7%
0.02%
-98.9%
Q4 2020$5,644,000
+6.6%
59,766
-1.8%
1.39%
-13.1%
Q3 2020$5,293,000
+0.6%
60,868
+1.1%
1.60%
-14.3%
Q2 2020$5,260,000
+13.5%
60,226
+7.2%
1.87%
-22.1%
Q1 2020$4,633,000
-11.6%
56,196
+1.6%
2.40%
-3.0%
Q4 2019$5,238,000
+6.9%
55,321
-1.9%
2.47%
-6.9%
Q3 2019$4,902,000
-4.1%
56,411
+0.7%
2.66%
-10.5%
Q2 2019$5,114,000
-5.3%
56,006
-0.3%
2.97%
-6.3%
Q1 2019$5,399,000
+11.6%
56,156
-0.4%
3.17%
+0.0%
Q4 2018$4,839,000
-19.1%
56,393
-18.8%
3.16%
+2.5%
Q3 2018$5,985,000
+20.1%
69,463
+5.3%
3.09%
+15.1%
Q2 2018$4,984,000
-7.8%
65,973
-1.3%
2.68%
-9.3%
Q1 2018$5,407,000
+0.2%
66,873
+4.1%
2.96%
+0.3%
Q4 2017$5,394,000
-3.5%
64,248
-1.3%
2.95%
-10.5%
Q3 2017$5,590,000
+2.9%
65,108
+0.0%
3.29%
-3.2%
Q2 2017$5,433,000
+44.8%
65,090
+28.8%
3.40%
+45.2%
Q1 2017$3,752,000
+2.7%
50,525
+0.7%
2.34%
+2.1%
Q4 2016$3,655,000
-9.9%
50,175
-2.3%
2.30%
-11.7%
Q3 2016$4,055,000
-10.4%
51,350
-6.4%
2.60%
-11.6%
Q2 2016$4,526,000
+20.2%
54,850
+5.5%
2.94%
+16.9%
Q1 2016$3,765,000
-17.8%
51,970
-2.4%
2.51%
-14.5%
Q4 2015$4,581,000
+13.7%
53,245
+21.5%
2.94%
+4.6%
Q3 2015$4,028,000
-7.7%
43,820
-1.2%
2.81%
+6.4%
Q2 2015$4,363,000
+0.2%
44,370
+0.5%
2.64%
-0.9%
Q1 2015$4,356,000
+4.8%
44,170
-1.5%
2.67%
+5.2%
Q4 2014$4,157,000
-21.4%
44,860
-20.1%
2.54%
-17.7%
Q3 2014$5,286,000
+4.1%
56,160
+0.1%
3.08%
+11.3%
Q2 2014$5,079,000
+20.1%
56,105
+12.8%
2.77%
+3.9%
Q1 2014$4,229,000
+5.4%
49,745
-0.3%
2.66%
+3.3%
Q4 2013$4,011,000
+5.4%
49,895
+0.6%
2.58%
+0.5%
Q3 2013$3,806,000
+11.4%
49,620
+2.7%
2.57%
+5.5%
Q2 2013$3,417,00048,3202.43%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders